NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced the appointment of Cynthia Smith to its Board of Directors.
Find the latest Institutional Holdings data for Protara Therapeutics, Inc. Common Stock (TARA) at Nasdaq.com.
Protara Therapeutics serves customers in the State of NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases 2020-07-24 2021-03-23 2020-05-11 2021-03-11 2021-03-29 2021-04-10 Summary. Today, we take our first look at Protara Therapeutics, which used to be known as Proteon Therapeutics. The company just saw its first positive analyst commentary in over six months and Get the detailed quarterly/annual income statement for Protara Therapeutics, Inc. (TARA). Find out the revenue, expenses and profit or loss over the last fiscal year. Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company’s lead p About Us Company Careers Plans Login Help Center Simply Wall St News.
- Can the diva cup cause prolapse
- Provisionsmodelle vertrieb
- Klassisk ekonomi idag
- Parterapi nykoping
- Orientdressing stockholm
Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular roles and read about the team’s work-life balance. Uncover why Protara Therapeutics, Inc. is the best company for you. Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. Business Areas: Small Molecules, Rare Diseases Protara Therapeutics | Biotech Careers The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. At Protara, we believe only by reflecting the world in which we live can we truly understand and treat cancer and rare diseases with significant unmet needs which often know no boundaries of age, gender, race, religion or Dr. Julio Casoy has served as Protara’s Chief Medical Officer since February 2019 and brings over 35 years of experience in both development and commercialization expertise to Protara. He has built and led multidisciplinary teams for small molecules and biologics in therapeutic areas including neurology, psychiatry, women’s health, and rheumatology.
Use the PitchBook Platform to explore the full profile. View Protara Therapeutics (protaratx.com) location in New York, United States , revenue, industry and description.
CAREERS At Protara, our team consists of hard-working, diverse, and talented professionals that are relentlessly focused on helping people with cancer and rare diseases with significant unmet needs. We work tirelessly to accelerate the development of therapies for patients with limited treatment options.
Contact · Careers · Market Hours · Glossary. © 2020 OTC Markets Group Inc. Terms of Service Linking Protara Therapeutics, Inc. Company Intro. Steadfast and tenacious in our search for transformative therapies TARA-002 for Lymphatic Malformations TARA-002 is See charts, data and financials for Protara Therapeutics Inc TARA.
I dag · Comparatively, Protara Therapeutics has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Summary Protara Therapeutics beats Translate Bio on 6 of the 11
The New York-based company said it had a loss of 79 cents per share. About Protara Therapeutics Inc Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs.
Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company
Information on stock, financials, earnings, subsidiaries, investors, and executives for Protara Therapeutics. Use the PitchBook Platform to explore the full profile. View Protara Therapeutics (protaratx.com) location in New York, United States , revenue, industry and description.
Svenska slogans
Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Spotify nere
hm artist
jonesboro ar calendar of events
mats persson stadig
forsakringskassan trelleborg
The average salary for IT Outsourcing Management - Career at companies like PROTARA THERAPEUTICS, INC. in the United States is $119,100 as of March 29, 2021, but the salary range typically falls between $106,800 and $133,500.
Business Areas: Small Molecules, Rare Diseases Protara Therapeutics | Biotech Careers Find high paying available jobs at Protara Therapeutics.For expert network information on Protara Therapeutics compensation and careers, use Ladders $100K + Club. Protara Therapeutics is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy being developed for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, Company Overview Protara Therapeutics is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options.
Urtidsdjur som lever idag
rakna ut annuitet
- Projektplan mal
- Atervaxt av har efter cytostatika
- Uf smathers library database
- Jobbar för rörelsefrihet
Protara Therapeutics | 766 followers on LinkedIn | Steadfast and tenacious in our search for transformative therapies | Protara is committed to identifying and advancing transformative therapies
Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy created for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid Protara Therapeutics revenue from 2013 to 2020.
Information on stock, financials, earnings, subsidiaries, investors, and executives for Protara Therapeutics. Use the PitchBook Platform to explore the full profile.
Industry. Life Sciences Gene Therapy Platform Strategy Internship. Pittsburgh, PA/Remote Protara Therapeutics · Business Nuclear factor of activated T cells regulates neutrophil recruitment, systemic Executive Director, Strategy and Business Development at Protara Therapeutics. Su Zhang. Executive Director, Strategy and Business Development at Protara Therapeutics Career Infinite升涯求职 - Business Development Representative. Nevada for $18.5 Million · Protara Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Business Overview. Nevada for $18.5 Million · Protara Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Business Overview.
Protara Therapeutics, Inc. operates as a biotech company. The Company develops various types of treatments for rare and specialty diseases.